Unknown

Dataset Information

0

Autologous CLL cell vaccination early after transplant induces leukemia-specific T cells.


ABSTRACT: Patients with advanced hematologic malignancies remain at risk for relapse following reduced-intensity conditioning (RIC) allogeneic hematopoietic stem cell transplantation (allo-HSCT). We conducted a prospective clinical trial to test whether vaccination with whole leukemia cells early after transplantation facilitates the expansion of leukemia-reactive T cells and thereby enhances antitumor immunity.We enrolled 22 patients with advanced chronic lymphocytic leukemia (CLL), 18 of whom received up to 6 vaccines initiated between days 30 and 45 after transplantation. Each vaccine consisted of irradiated autologous tumor cells admixed with GM-CSF-secreting bystander cells. Serial patient PBMC samples following transplantation were collected, and the impact of vaccination on T cell activity was evaluated.At a median follow-up of 2.9 (range, 1-4) years, the estimated 2-year progression-free and overall survival rates of vaccinated subjects were 82% (95% CI, 54%-94%) and 88% (95% CI, 59%-97%), respectively. Although vaccination only had a modest impact on recovering T cell numbers, CD8+ T cells from vaccinated patients consistently reacted against autologous tumor, but not alloantigen-bearing recipient cells with increased secretion of the effector cytokine IFN-?, unlike T cells from nonvaccinated CLL patients undergoing allo-HSCT. Further analysis confirmed that 17% (range, 13%-33%) of CD8+ T cell clones isolated from 4 vaccinated patients by limiting dilution of bulk tumor-reactive T cells solely reacted against CLL-associated antigens.Our studies suggest that autologous tumor cell vaccination is an effective strategy to advance long-term leukemia control following allo-HSCT.Clinicaltrials.gov NCT00442130.NCI (5R21CA115043-2), NHLBI (5R01HL103532-03), and Leukemia and Lymphoma Society Translational Research Program.

SUBMITTER: Burkhardt UE 

PROVIDER: S-EPMC3754265 | biostudies-literature | 2013 Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications


<h4>Background</h4>Patients with advanced hematologic malignancies remain at risk for relapse following reduced-intensity conditioning (RIC) allogeneic hematopoietic stem cell transplantation (allo-HSCT). We conducted a prospective clinical trial to test whether vaccination with whole leukemia cells early after transplantation facilitates the expansion of leukemia-reactive T cells and thereby enhances antitumor immunity.<h4>Methods</h4>We enrolled 22 patients with advanced chronic lymphocytic le  ...[more]

Similar Datasets

| S-EPMC3755905 | biostudies-literature
| S-EPMC5510147 | biostudies-other
| S-EPMC9980861 | biostudies-literature
| S-EPMC3867129 | biostudies-literature
| S-EPMC3769940 | biostudies-literature
| S-EPMC2747203 | biostudies-other
| S-EPMC5980379 | biostudies-literature
| S-EPMC9285346 | biostudies-literature
| S-EPMC4704136 | biostudies-literature
| S-EPMC4334757 | biostudies-literature